Track topics on Twitter Track topics that are important to you
Diabetes management provider Glooko has unveiled new version of the Glooko Web Application (Population Tracker) that includes streamlined navigation and a large array of diabetes analytics, charts and...
Russ Johannesson pushed back on the idea that he is the CEO whose sole goal is to take the company to an exit, opined on competitors like Livongo, and said Glooko is the connective tissue across the d...
Glooko, the leader in diabetes data management, today announced participation in the 78th Annual American Diabetes Association meeting taking place this weekend in Orlando, Fla.
Interviews with Glooko’s previous CEO, new CEO and a Novo Nordisk executive show that the two company’s messaging around the development of a smart insulin pen is not aligne
Poster to be presented at the 2018 American Association of Clinical Endocrinologists annual meeting Glooko, the leader in diabetes data management, today announced the ...
Glooko, the leader in diabetes data management, today announced the results of its recent study which examined diabetes healthcare professionals' use of CGM data.
New version features support for the Ambulatory Glucose Profile (AGP), new dashboards and reports Glooko, the leader in diabetes data management, today announced the de...
Growth and international expansion drive new addition to leadership team Glooko, the leader in diabetes data management, today announced the appointment of Russ ...
The purpose of this study is to compare HbA1c of insulin-treated subjects with type 2 diabetes managed via usual care alone and usual care augmented with remote monitoring using Glooko
This is a two-armed mixed methods study of participants (n=30) diagnosed with type 2 diabetes who use a blood glucose meter as part of their treatment regimen. Participants will have eithe...
This is an open label randomized, controlled, parallel intervention study. Group 1 will receive usual care for insulin degludec titration using the STEP WISE degludec titration algorithm G...
The purpose of this pilot study is to determine if training and support, combined with reminders to facilitate glucose data sharing with the diabetes care team in between clinic visits, ca...
This study will use a randomized, crossover design. Children aged 13-18 years who have been diagnosed with Type 1 diabetes for at least 1 year and with at least 2 Hemoglobin A1c values ≥...
Glooko is the leading diabetes data management platform and is trusted by the worldâs leaders in diabetes care. Over 6,000 providers in 27 countries use Glookoâs FDA-cle...
Glooko provides insights into diabetes by enabling both people with diabetes (PWDs) and their care teams with technology to understand and manage diabetes care. Our self-managemen...
We have published hundreds of Glooko, Inc. news stories on BioPortfolio along with dozens of Glooko, Inc. Clinical Trials and PubMed Articles about Glooko, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glooko, Inc. Companies in our database. You can also find out about relevant Glooko, Inc. Drugs and Medications on this site too.
Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...